Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease

Multiple myeloma (MM) is the most common malignant monoclonal disease of plasma cells. Aside from classical chemotherapy and glucocorticoids, proteasome inhibitors, immunomodulatory agents and monoclonal antibodies are used in the current treatment scheme of MM. The tumor microenvironment (TME) play...

Descripción completa

Detalles Bibliográficos
Autores principales: Forster, Stefan, Radpour, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284036/
https://www.ncbi.nlm.nih.gov/pubmed/35847862
http://dx.doi.org/10.3389/fonc.2022.941437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284036/
https://www.ncbi.nlm.nih.gov/pubmed/35847862
http://dx.doi.org/10.3389/fonc.2022.941437

Ejemplares similares